Growth Hormone Deficiency: Strategies and Indications to Continue Growth Hormone Therapy in Transition from Adolescence to Adult Life
- 1 July 2003
- journal article
- review article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 60 (Suppl. 1) , 78-85
- https://doi.org/10.1159/000071231
Abstract
The most common practice in children with growth hormone (GH) deficiency is to discontinue GH treatment in adolescence after attainment of final height. Childhood-onset GH deficiency (GHD) that continues into adulthood and is not treated may be associated with more severe consequences than GHD acquired as an adult. This raises the question of the importance of GH for continuing tissue maturation after longitudinal growth has stopped. Data from recent studies suggest that muscle and bone maturation is arrested when GH treatment is discontinued at final height in adolescents in whom severe GHD continues into adulthood. These patients also develop, even in the short term, well-known cardiovascular risk factors associated with GHD in adults. Retesting for GHD is crucial in adolescence because a considerable number of patients will not have severe GHD according to the criteria set for adults. Continuing replacement therapy in these patients is warranted, but cost-benefit comparisons of treatment are still under debate and a lack of acceptance, and hence reimbursement, for such treatment is still common. In this review, the management and organization of transition, with and without continuing GH replacement therapy, are also discussed.Keywords
This publication has 40 references indexed in Scilit:
- Baseline Characteristics and the Effects of Five Years of GH Replacement Therapy in Adults with GH Deficiency of Childhood or Adulthood Onset: A Comparative, Prospective StudyJournal of Clinical Endocrinology & Metabolism, 2001
- A Prospective Study of 5 Years of GH Replacement Therapy in GH-Deficient Adults: Sustained Effects on Body Composition, Bone Mass, and Metabolic IndicesJournal of Clinical Endocrinology & Metabolism, 2001
- Critical Evaluation of the Safety of Recombinant Human Growth Hormone Administration: Statement from the Growth Hormone Research SocietyJournal of Clinical Endocrinology & Metabolism, 2001
- Continuation of Growth Hormone (GH) Therapy in GH-Deficient Patients during Transition from Childhood to Adulthood: Impact on Insulin Sensitivity and Substrate MetabolismJournal of Clinical Endocrinology & Metabolism, 2000
- Continuation of Growth Hormone (GH) Replacement in GH-Deficient Patients during Transition from Childhood to Adulthood: A Two-Year Placebo-Controlled StudyJournal of Clinical Endocrinology & Metabolism, 2000
- Consensus Guidelines for the Diagnosis and Treatment of Adults with Growth Hormone Deficiency: Summary Statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone DeficiencyJournal of Clinical Endocrinology & Metabolism, 1998
- Two Years of Growth Hormone (GH) Treatment Increase Isometric and Isokinetic Muscle Strength in GH-Deficient AdultsJournal of Clinical Endocrinology & Metabolism, 1997
- A Low Starting Dose of Genotropin in Growth Hormone-Deficient AdultsJournal of Clinical Endocrinology & Metabolism, 1997
- The individual responsiveness to growth hormone (GH) treatment in GH- deficient adults is dependent on the level of GH-binding protein, body mass index, age, and genderJournal of Clinical Endocrinology & Metabolism, 1996
- Diagnosis of growth-hormone deficiency in adultsThe Lancet, 1994